Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Marc J. Cohen, Christine Demers, Enrique Gurfinkel et al. · New England Journal of Medicine · 1997 · 1.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

Dagmar Kubitza, Michael Becka, Barbara Voith et al. · Clinical Pharmacology & Therapeutics · 2005 · 652 citations

Medicine, Pharmacokinetics, Pharmacology +16

Kinetics of the inhibition of thrombin by hirudin

Stuart R. Stone, Jan Hofsteenge · Biochemistry · 1986 · 584 citations

Life Sciences, Biochemistry, Molecular Biology +17

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

Elisabeth Perzborn, Andreas Wilmen, Jens Pohlmann et al. · Journal of Thrombosis and Haemostasis · 2005 · 584 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic Enzymes

Thomas Antonsson, Ulf G. Eriksson, Erika Gyzander et al. · Thrombosis and Haemostasis · 1998 · 209 citations

Medicine, Pharmacology, Pharmacotherapy +17